Form 4: Becton Dickinson Executive Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Shana Carol Neal, EVP and Chief People Officer at Becton Dickinson, sold 787 shares of common stock at $240 per share on January 21, 2025, under a pre-arranged 10b5-1 trading plan.
Summary
- Shana Carol Neal, an Executive Vice President and Chief People Officer at Becton Dickinson & Co., sold 787 shares of the company's common stock on January 21, 2025.
- The sale was executed at a price of $240 per share.
- This transaction was conducted under a pre-arranged Rule 10b5-1 trading plan adopted on September 6, 2024.
- Following the transaction, Ms. Neal directly owns 15,414 shares of Becton Dickinson common stock.
Sentiment
Score: 5
Explanation: The document is a routine Form 4 filing for an executive stock sale under a pre-arranged plan, indicating a neutral sentiment.
Industry Context
Executive stock sales are a common occurrence and are often part of pre-planned strategies, such as 10b5-1 plans, to avoid accusations of insider trading. This transaction is not unusual for executives at publicly traded companies.
Comparison to Industry Standards
- Executive stock sales are a common practice across publicly traded companies, including those in the medical device and healthcare sector like Medtronic (MDT) and Abbott Laboratories (ABT).
- These sales are often conducted under pre-arranged 10b5-1 plans to comply with insider trading regulations.
- The volume of shares sold by Ms. Neal is relatively small compared to the total outstanding shares of Becton Dickinson, and is not unusual for an executive at her level.
- Similar filings can be seen from executives at other large medical device companies, such as Stryker (SYK) and Boston Scientific (BSX), indicating this is a standard practice.
Stakeholder Impact
- The stock sale by an executive may have a minor impact on shareholder sentiment, but is unlikely to significantly affect the company's stock price due to the pre-planned nature of the transaction.
Key Dates
| Date | Description |
|---|---|
| 09/06/2024 | Date the Rule 10b5-1 trading plan was adopted by the reporting person. |
| 01/21/2025 | Date of the stock sale transaction. |
| 01/22/2025 | Date of the signature on the Form 4 filing. |
Keywords
Becton Dickinson, Executive Stock Sale, Form 4, Rule 10b5-1, Insider Trading, Shana Carol Neal, BDX
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.